Cannabis Stock Movers For December 28, 2023
Portfolio Pulse from Benzinga Insights
On December 28, 2023, several cannabis stocks experienced significant price movements. Notable gainers included GrowLife, Rhinomed, AusCann Group Holdings, Khiron Life Sciences, and Cara Therapeutics, with GrowLife leading the surge with a 200% increase. On the losing end, The Flowr Corporation saw a dramatic 99.99% decline. Other decliners included CordovaCann, Rocky Mountain High, and Item 9 Labs. The cannabis sector showed high volatility with these sharp price changes.
December 28, 2023 | 9:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cara Therapeutics shares closed up 17.78% at $0.78, indicating a strong positive performance for the day.
Cara Therapeutics' significant daily gain suggests positive investor sentiment or reaction to specific company news, which could lead to increased short-term interest and potentially higher prices.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
SNDL shares closed up 7.10% at $1.66, showing a positive trend for the day.
The rise in SNDL's stock price could attract more attention from investors, potentially leading to further short-term gains as the market responds to the positive momentum.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Tilray Brands shares increased by 7.59% to close at $2.41, reflecting a positive day for the company.
Tilray Brands' stock appreciation indicates investor confidence, which may lead to continued short-term upward price movement as market participants react to the day's gains.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Urban-gro shares ended the day up 6.77% at $1.42, marking a positive performance.
Urban-gro's stock price increase could suggest a bullish outlook among investors, potentially leading to further short-term price increases as the market digests the positive close.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
cbdMD shares saw an 11.25% increase, closing at $0.79, indicating investor optimism.
The significant rise in cbdMD's stock price could lead to continued investor interest in the short term, potentially driving the price up further as the market reacts.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Psychemedics shares closed down 7.39% at $2.63, showing a negative trend for the day.
Psychemedics' decline in stock price could lead to short-term bearish sentiment among investors, potentially causing further downward pressure on the stock price.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60